Medaxiom Blog

One of the joys – and responsibilities – of MedAxiom is being on the forefront of cardiovascular care. As readers of this blog already know, cardiovascular care is complex in a number of ways. Whether it’s staffing, technology, finances, operations, clinical care, lab optimization, care team development, sites of service and more, the evolutions and solutions are typically hyper-focused on specific organizational challenges and disease states. While there are industry-wide shifts that are often driven by reimbursement changes, it is more common that cardiovascular programs focus on these subsets of care delivery at various times depending on their evolution and overall program strategy. MedAxiom is dedicated to providing solutions for all areas of cardiovascular operational and clinical improvement, thereby accommodating entities that travel in and out of stages of need. Whether a program is focusing on care team optimization, developing a remote patient monitoring program, embarking on a CT journey, seeking cath lab operational efficiency, or pursuing other opportunities, MedAxiom aims to provide cardiovascular programs with the right solution at the right time.

It seems as though every day I hear about the next big thing. Sometimes there is merit, and sometimes there isn’t. There is undoubtedly merit to the coming changes in Transcatheter Aortic Valve Replacement (TAVR), and they are exciting. The changes are going to revolutionize how we use TAVR and how we contract to provide TAVR services. By contracting for TAVR, I’m referring to ways in which TAVR services are sold, which can mean negotiating with private payers, participating in bundles with CMS via BPCI-A, or working with jumbo employers to create bundles for TAVR procedures.

Every day I am thrilled to have the opportunity to be on the leading edge of healthcare innovation. A part of that leading edge is a full visual into transformative technologies and trends impacting the cardiovascular market. One trend that is beginning to cement itself as a rock-solid strategy is the evolution of the Cardiovascular Ambulatory Surgical Center (ASC). The Office Based Lab (OBL) has been a great strategy as an extension of practice, but moving into a recognized ASC facility (or creating a hybrid OBL/ASC) allows versatility and diversification if volumes or payment rates change over time, as they are sure to do across procedures and specialties.